Financials Albert Labs International Corp. OTC Markets
Equities
ALBLF
CA0127841041
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
-.--% | -.--% |
Valuation
Fiscal Period: December | 2022 |
---|---|
Capitalization 1 | 2.727 |
Enterprise Value (EV) 1 | 2.647 |
P/E ratio | -0.32 x |
Yield | - |
Capitalization / Revenue | - |
EV / Revenue | - |
EV / EBITDA | -639,787 x |
EV / FCF | -1,489,163 x |
FCF Yield | -0% |
Price to Book | -7.46 x |
Nbr of stocks (in thousands) | 68,163 |
Reference price 2 | 0.0400 |
Announcement Date | 02/06/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net sales | - | - | - |
EBITDA | - | -1.877 | -4.138 |
EBIT 1 | -1.733 | -1.879 | -4.141 |
Operating Margin | - | - | - |
Earnings before Tax (EBT) 1 | -1.733 | -1.879 | -7.059 |
Net income 1 | -1.733 | -1.879 | -7.059 |
Net margin | - | - | - |
EPS 2 | -0.3023 | -0.0473 | -0.1251 |
Free Cash Flow | - | -0.3454 | -1.778 |
FCF margin | - | - | - |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 15/03/22 | 09/06/22 | 02/06/23 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net Debt 1 | - | - | - |
Net Cash position 1 | 0.01 | 0.08 | 0.08 |
Leverage (Debt/EBITDA) | - | - | - |
Free Cash Flow | - | -0.35 | -1.78 |
ROE (net income / shareholders' equity) | - | 1,553% | 1,627% |
ROA (Net income/ Total Assets) | - | -362% | -993% |
Assets 1 | - | 0.5192 | 0.7112 |
Book Value Per Share 2 | 0.0100 | -0.0100 | -0.0100 |
Cash Flow per Share 2 | 0 | 0 | 0 |
Capex | - | 0.14 | 0.06 |
Capex / Sales | - | - | - |
Announcement Date | 15/03/22 | 09/06/22 | 02/06/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.85% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- ABRT Stock
- ALBLF Stock
- Financials Albert Labs International Corp.